Professor at Galgotias University, India
Dr. Sheryene Tejeda is a distinguished medical scientist based in Palm Beach Gardens, Florida, with a profound commitment to advancing healthcare through research and integrative therapies. With over 15 years of extensive experience in clinical and scientific environments, she has established herself as a leader in medical research and protocol development. Dr. Tejeda’s diverse background spans multiple domains, including oncology, neurology, and behavioral health, where she has significantly contributed to the understanding and treatment of complex medical conditions. Her passion for bridging scientific discovery and clinical practice drives her innovative approaches to improving patient care and health outcomes.
Professional Profile
Education
Dr. Tejeda holds an impressive educational background, starting with a Bachelor’s degree in Communications and Psychology, which laid the foundation for her understanding of human behavior and communication in healthcare. She furthered her education with a Master’s in Forensic Science, enhancing her analytical skills in evidence evaluation and research methodologies. Dr. Tejeda then obtained a Master’s in Health Science, focusing on the integration of scientific knowledge into practical health solutions. Most notably, she earned her PhD in Biomedical Science from Einstein Medical School, where her research emphasized the intersection of molecular biology and clinical applications. This robust educational foundation has empowered her to navigate complex scientific inquiries and contribute meaningfully to her field.
Professional Experience
Throughout her career, Dr. Tejeda has held various pivotal roles that highlight her expertise and leadership in the medical field. As a Lead Medical Scientist at Medicinal Technologies, she spearheaded projects aimed at developing innovative therapeutic protocols, collaborating with multidisciplinary teams to ensure the efficacy and safety of new treatments. Additionally, her work as a Contract Co-occurring Consultant allowed her to address the complexities of patients with concurrent medical and behavioral health issues. As a Clinical Research Associate, she has managed numerous clinical trials, ensuring compliance with regulatory standards while advocating for patient safety. Dr. Tejeda’s professional experience reflects her commitment to advancing medical knowledge and improving healthcare delivery through research and collaboration.
Research Interests
Dr. Tejeda’s research interests are deeply rooted in the pursuit of integrative therapies and their applications in clinical settings. She is particularly focused on the intersection of oncology and neurology, exploring how innovative treatment modalities can enhance patient outcomes and quality of life. Her work encompasses the investigation of co-occurring medical conditions and their impact on treatment efficacy, emphasizing the need for comprehensive care approaches. Dr. Tejeda is also dedicated to the development of evidence-based protocols that bridge the gap between scientific research and clinical practice, advocating for the incorporation of holistic methodologies in patient management. Her research endeavors are driven by a desire to contribute to the advancement of personalized medicine and improve the overall healthcare landscape.
Awards and Honors
Throughout her illustrious career, Dr. Sheryene Tejeda has been recognized for her outstanding contributions to the medical research community. She has received several prestigious awards for her innovative research and dedication to patient care, underscoring her impact in the field. Among her accolades, Dr. Tejeda was honored with the Excellence in Research Award at Einstein Medical School for her groundbreaking doctoral dissertation, which has been cited widely in subsequent studies. Additionally, her leadership in clinical trials has garnered recognition from multiple healthcare organizations, further solidifying her reputation as a leading expert in her field. Dr. Tejeda’s commitment to excellence and her relentless pursuit of knowledge continue to inspire her colleagues and students alike.
Conclusion
Dr. Prem Shankar Mishra is a strong candidate for the Best Researcher Award, given his impressive academic credentials, substantial research contributions, effective leadership, and commitment to advancing pharmaceutical sciences. By addressing the suggested areas for improvement, he can further elevate his research profile and enhance his contributions to the field. His dedication to mentoring the next generation of researchers and fostering collaboration positions him as a valuable asset to the academic and scientific community.
Publication top noted
- 📖 Novel 2-pyridone Analogs with Anti-cancer Activity: Synthesis, In silico, and In vitro Evaluation
🗓 Year: 2024
🔗 DOI: 10.2174/1570180820666230223113234
📝 Contributors: Prem Shankar Mishra, Velayutham Ravichandiran, Rakhi Mishra
- 📖 Comprehensive Review on Alzheimer’s Disease: Natural Therapeutics, Gaps and Challenges
🗓 Year: 2024
🔗 DOI: 10.2174/0118715249307525240614073143
📝 Contributors: Prem Shankar Mishra, Rakhi Mishra, Anuj Kumar
- 📖 Role of Natural Secondary Metabolites as HIF-1 Inhibitors in Cancer Therapy
🗓 Year: 2024
🔗 DOI: 10.1007/s00044-024-03219-x
📝 Contributors: Prem Shankar Mishra, Rakhi Mishra, Vaishali Manikrao Patil, Samiksha Dewangan
- 📖 A Comprehensive Study on Synthesis and Biological Activities of Pyridazine Derivatives
🗓 Year: 2021
🔗 DOI: 10.52711/0974-360X.2021.00595
📝 Contributors: Malik, A.; Mishra, R.; Mazumder, R.; Mazumder, A.; Mishra, P.S.
- 📖 Computational Docking Technique for Drug Discovery: A Review
🗓 Year: 2021
🔗 DOI: 10.52711/0974-360X.2021.00968
📝 Contributors: Mishra, R.; Mishra, P.S.; Mazumder, R.; Mazumder, A.; Chaudhary, A.
- 📖 Therapeutic Potential of Herbal Molecules Against Breast Cancer
🗓 Year: 2021
🔗 DOI: 10.2174/1573401317666210111110556
📝 Contributors: Prem Shankar Mishra
- 📖 Efficient Green Synthesis and Biological Evaluation of Thiadiazole Derivatives
🗓 Year: 2021
🔗 DOI: 10.33263/lianbs103.25942604
📝 Contributors: Prem Shankar Mishra
- 📖 Design, Synthesis, and Characterization of 2-Pyridone Derivatives as c-Jun N-Terminal Kinases (JNKs) Signaling Pathway Inhibitors
🗓 Year: 2017
🔗 DOI: 10.5958/0974-360X.2017.00684.9
📝 Contributors: Mishra, P.S.; Vijey Aanandhi, M.; Ravichandiran, V.
- 📖 Synthesis, Characterization and Antitumor Potential of Cinnamoyl Urea Derivatives
🗓 Year: 2016
🔗 DOI: 10.14233/ajchem.2016.19403
📝 Contributors: Chaudhary, R.; Shuaib, M.; Hashim, S.R.; Mishra, P.S.
- 📖 Synthesis, Characterization and Free Radical Scavenging Activity of 2-Azetidinone Derivatives
🗓 Year: 2015
🔗 DOI: Not available
📝 Contributors: Mishra, P.S.; Himanshu; Gupta, S.K.; Mishra, R.
- 📖 Synthesis, Characterization and Tubulin-Interaction Profile of Substituted Cinnamoyl Urea Derivatives
🗓 Year: 2015
🔗 DOI: Not available
📝 Contributors: Chaudhary, R.; Shuaib; Riaz Hashim, S.; Mishra, P.S.
- 📖 A Review on the Vanillin Derivatives Showing Various Biological Activities
🗓 Year: 2012
🔗 DOI: Not available
📝 Contributors: Kumar, R.; Sharma, P.K.; Mishra, P.S.
- 📖 A Review on Herbal Antidiabetic Drugs
🗓 Year: 2011
🔗 DOI: Not available
📝 Contributors: Mishra, R.; Shuaib, M.; Shravan; Mishra, P.S.
- 📖 Synthesis, Antimicrobial and Sedative Hypnotic Activity of Cinnamoyl Ureas
🗓 Year: 2011
🔗 DOI: Not available
📝 Contributors: Vijey Aanandhi, M.; Mishra, P.S.; George, S.; Chaudhary, R.